Our Products


Otsuka Canada Pharmaceutical Inc. (OCPI) is an innovative, fast-growing health care company that commercializes Otsuka medicines in Canada, with a focus on commitment to neuroscience, cardiovascular, and oncology. OCPI is dedicated to improving patients' health and the quality of human life. 


Fraudulent Solicitations For Investment, Scam Recruiting or Business Opportunities

Read notice


    February 17, 2017

    Tokyo, Japan and Montreal, Canada, February 16, 2017– Otsuka Pharmaceutical Co., Ltd. (Otsuka) and Lundbeck Canada announce that Health Canada issued a Notice of Compliance for REXULTI™ (brexpiprazole) for the treatment of schizophrenia in adults. REXULTI™ was discovered by Otsuka and co-developed with Lundbeck. It will be co-marketed by the two companies and is expected to become commercially available in Canada this spring.

    Read More


Start a new Story at Otsuka

Come and work with a team of people who aren’t afraid to challenge convention. This approach can lead to something new, something better.

We aspire to attract best-in-class people and partners. After all, having the right team makes all the difference.

We encourage our employees to dream.  Then we give them the freedom to reach for those dreams.

What is your story going to be?
View All Careers
Who We Are

Otsuka Canada Pharmaceutical Inc. (OCPI) is dedicated to improving patients' health and the quality of human life.

Our Culture

The Otsuka culture and big venture approach is our everyday story and competitive advantage.

Our History

Since 1921 we have nurtured the spirit of curiosity, creativity, and perseverance in our people, to bring healthcare products to patients worldwide.

Community Support

Find out more about how OCPI supports medical education and our involvement in the community.


OCPI has it's headquarters in Technoparc Montreal, in St-Laurent, Quebec.

Contact Us

1 888 997-9017
514 332-3001

2250 Alfred-Nobel Boulevard,
St-Laurent, Quebec,
Suite 301
H4S 2C9